Verrica Pharmaceuticals Inc. (VRCA) Net income 2017–2025
Verrica Pharmaceuticals Inc. (VRCA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$17.9MFY2025 · since FY2017: -$4.5M → -$17.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$17.9M | +76.6% |
| FY2024 | -$76.6M | -14.3% |
| FY2023 | -$67.0M | -173.6% |
| FY2022 | -$24.5M | +30.2% |
| FY2021 | -$35.1M | +17.8% |
| FY2020 | -$42.7M | -51.4% |
| FY2019 | -$28.2M | -36.6% |
| FY2018 | -$20.6M | -363.1% |
| FY2017 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice